AtriCure Inc. (ATRC)
AtriCure Statistics
Share Statistics
AtriCure has 48.88M shares outstanding. The number of shares has increased by 1.03% in one year.
| Shares Outstanding | 48.88M |
| Shares Change (YoY) | 1.03% |
| Shares Change (QoQ) | 0.26% |
| Owned by Institutions (%) | 98.59% |
| Shares Floating | 47.13M |
| Failed to Deliver (FTD) Shares | 10 |
| FTD / Avg. Volume | < 0.01% |
Short Selling Information
The latest short interest is 1.47M, so 3.02% of the outstanding shares have been sold short.
| Short Interest | 1.47M |
| Short % of Shares Out | 3.02% |
| Short % of Float | 3.12% |
| Short Ratio (days to cover) | 2.97 |
Valuation Ratios
The PE ratio is -32.21 and the forward PE ratio is -67.66. AtriCure's PEG ratio is -0.73.
| PE Ratio | -32.21 |
| Forward PE | -67.66 |
| PS Ratio | 3.09 |
| Forward PS | 1.9 |
| PB Ratio | 3.12 |
| P/FCF Ratio | 117.96 |
| PEG Ratio | -0.73 |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for AtriCure.
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.65, with a Debt / Equity ratio of 0.17.
| Current Ratio | 3.65 |
| Quick Ratio | 2.62 |
| Debt / Equity | 0.17 |
| Debt / EBITDA | -4.13 |
| Debt / FCF | 6.27 |
| Interest Coverage | -6.25 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| Return on Equity | n/a |
| Return on Assets | n/a |
| Return on Invested Capital | n/a |
| Revenue Per Employee | $357.93K |
| Profits Per Employee | $-34.38K |
| Employee Count | 1,300 |
| Asset Turnover | 0.76 |
| Inventory Turnover | 1.56 |
Taxes
| Income Tax | 1.02M |
| Effective Tax Rate | -2.34% |
Stock Price Statistics
The stock price has increased by 25.89% in the last 52 weeks. The beta is 1.65, so AtriCure's price volatility has been higher than the market average.
| Beta | 1.65 |
| 52-Week Price Change | 25.89% |
| 50-Day Moving Average | 37.45 |
| 200-Day Moving Average | 30.82 |
| Relative Strength Index (RSI) | 42.13 |
| Average Volume (20 Days) | 615.57K |
Income Statement
In the last 12 months, AtriCure had revenue of 465.31M and earned -44.7M in profits. Earnings per share was -0.95.
| Revenue | 465.31M |
| Gross Profit | 347.52M |
| Operating Income | -40.01M |
| Net Income | -44.7M |
| EBITDA | -18.53M |
| EBIT | -37.27M |
| Earnings Per Share (EPS) | -0.95 |
Balance Sheet
The company has 122.72M in cash and 76.53M in debt, giving a net cash position of 46.19M.
| Cash & Cash Equivalents | 122.72M |
| Total Debt | 76.53M |
| Net Cash | 46.19M |
| Retained Earnings | -401.75M |
| Total Assets | 609.33M |
| Working Capital | 194.4M |
Cash Flow
In the last 12 months, operating cash flow was 12.2M and capital expenditures 0, giving a free cash flow of 12.2M.
| Operating Cash Flow | 12.2M |
| Capital Expenditures | 0 |
| Free Cash Flow | 12.2M |
| FCF Per Share | 0.26 |
Margins
Gross margin is 74.69%, with operating and profit margins of -8.6% and -9.61%.
| Gross Margin | 74.69% |
| Operating Margin | -8.6% |
| Pretax Margin | -9.39% |
| Profit Margin | -9.61% |
| EBITDA Margin | -3.98% |
| EBIT Margin | -8.6% |
| FCF Margin | 2.62% |
Dividends & Yields
ATRC does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | n/a |
| FCF Yield | n/a |
Analyst Forecast
The average price target for ATRC is $50.5, which is 53.4% higher than the current price. The consensus rating is "Buy".
| Price Target | $50.5 |
| Price Target Difference | 53.4% |
| Analyst Consensus | Buy |
| Analyst Count | 10 |
Scores
| Altman Z-Score | 6.42 |
| Piotroski F-Score | 5 |